Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127073811 | 12707381 | 1 | I | 20160627 | 20160901 | 20160901 | EXP | CH-SA-2016SA120205 | AVENTIS | VALENTI A, CASUTT A, KOUTSOKERA A, NOETZLI J, PERENTES JY, KRUEGER T, ET AL. LATE MAJOR HEMOPTYSIS AFTER LUNG VOLUME REDUCTION WITH COILS INDUCED BY DUAL ANTIAGGREGATION THERAPY. ANN THORAC SURG 2016 FEB 01;101(2):E49-50. AVAILABLE FROM: HTTP://DX.DOI.ORG/10.1016/J.ATHORACSUR.2015.06.045. | 55.00 | YR | A | M | Y | 0.00000 | 20160901 | MD | CH | CH |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127073811 | 12707381 | 1 | PS | CLOPIDOGREL BISULFATE. | CLOPIDOGREL BISULFATE | 1 | Unknown | Y | N | UNKNOWN | 20839 | 75 | MG | QD | |||||
| 127073811 | 12707381 | 2 | SS | CLOPIDOGREL BISULFATE. | CLOPIDOGREL BISULFATE | 1 | Unknown | Y | N | UNKNOWN | 20839 | 75 | MG | QD | |||||
| 127073811 | 12707381 | 3 | SS | CLOPIDOGREL BISULFATE. | CLOPIDOGREL BISULFATE | 1 | Unknown | Y | N | UNKNOWN | 20839 | ||||||||
| 127073811 | 12707381 | 4 | SS | CLOPIDOGREL BISULFATE. | CLOPIDOGREL BISULFATE | 1 | Unknown | Y | N | UNKNOWN | 20839 | ||||||||
| 127073811 | 12707381 | 5 | SS | CLOPIDOGREL BISULFATE. | CLOPIDOGREL BISULFATE | 1 | Unknown | Y | N | UNKNOWN | 20839 | ||||||||
| 127073811 | 12707381 | 6 | SS | CLOPIDOGREL BISULFATE. | CLOPIDOGREL BISULFATE | 1 | Unknown | Y | N | UNKNOWN | 20839 | ||||||||
| 127073811 | 12707381 | 7 | SS | ASPIRIN. | ASPIRIN | 1 | Unknown | Y | UNKNOWN | 0 | 100 | MG | QD | ||||||
| 127073811 | 12707381 | 8 | SS | ASPIRIN. | ASPIRIN | 1 | Unknown | Y | UNKNOWN | 0 | 100 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127073811 | 12707381 | 1 | Anticoagulant therapy |
| 127073811 | 12707381 | 2 | Arthralgia |
| 127073811 | 12707381 | 3 | Anticoagulant therapy |
| 127073811 | 12707381 | 4 | Arthralgia |
| 127073811 | 12707381 | 5 | Anticoagulant therapy |
| 127073811 | 12707381 | 6 | Arthralgia |
| 127073811 | 12707381 | 7 | Anticoagulant therapy |
| 127073811 | 12707381 | 8 | Peripheral arterial occlusive disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127073811 | 12707381 | LT |
| 127073811 | 12707381 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127073811 | 12707381 | Accidental exposure to product | |
| 127073811 | 12707381 | Bronchoscopy abnormal | |
| 127073811 | 12707381 | Haemoptysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |